Sex differences in the renin-angiotensin-aldosterone system and its roles in hypertension, cardiovascular, and kidney

Sarah M Nwia1,2, Ana Paula O Leite3, Xiao Chun Li1,2

  • 1Tulane Hypertension and Renal Center of Excellence, Tulane University School of Medicine, New Orleans, LA, United States.

Insights

This review explores sex differences in hypertension, focusing on the renin-angiotensin system. Understanding these biological distinctions is key to developing tailored treatments for cardiovascular disease and improving patient outcomes.

Area of Science:

  • Cardiovascular physiology
  • Endocrinology
  • Hypertension research

Background:

  • Cardiovascular disease (CVD) exhibits significant biological sex differences, impacting prevention and treatment strategies.
  • Hypertension (high blood pressure) is a primary risk factor for CVD, stroke, and renal failure, affecting nearly half of American adults.
  • While women have lower hypertension rates during reproductive years, this protection diminishes post-menopause, and treatment-resistant cases highlight unclear underlying mechanisms.

Purpose of the Study:

  • To review recent advances in understanding sex-specific physiological mechanisms influencing the renin-angiotensin system and blood pressure control.
  • To discuss the role of genetic and hormonal differences in hypertension development.
  • To examine sex disparities in hypertension management, treatment efficacy, and patient outcomes.

Main Methods:

  • Literature review of recent research on sex differences in cardiovascular physiology.
  • Analysis of studies investigating the renin-angiotensin system in relation to sex hormones and blood pressure.
  • Synthesis of epidemiological data and clinical trial findings on hypertension in men and women.

Main Results:

  • Biological sex significantly influences cardiovascular disease pathology, including hypertension.
  • The renin-angiotensin system's function and its role in blood pressure regulation show distinct sex-based variations.
  • Menopause is a critical transition where women's hypertension risk approaches that of men.

Conclusions:

  • Tailoring hypertension prevention and treatment based on biological sex is crucial for improving patient outcomes.
  • Further research into sex-specific genetic and hormonal mechanisms is needed to address treatment-resistant hypertension.
  • Understanding sex differences in the renin-angiotensin system can lead to more effective, personalized therapeutic strategies.

Related Concept Videos

Hormonal Regulation01:33

Hormonal Regulation

The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
33.4K
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
20
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
699
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
698
Hormonal Regulation of Blood Pressure01:17

Hormonal Regulation of Blood Pressure

Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
2.7K
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.1K